Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer

Urology

Volumn 79, Issue 1, 2012, Pages 240.e9-240.e15

  Marín Aguilera, Mercedes ^a,b   Mengual, Lourdes ^a,b   Ribal, María José ^a   Ars, Elisabet ^b   Ríos, José ^a   Gázquez, Cristina ^a   Villavicencio, Humberto ^b   Alcaraz, Antonio ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b FUNDACIÓ PUIGVERT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; MESSENGER RNA; RNA DIRECTED DNA POLYMERASE;

ADULT; AGED; AGR2 GENE; ARTICLE; BLADDER CARCINOMA; BLOOD SAMPLING; C10ORF116 GENE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FXYD3 GENE; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; KRT19 GENE; KRT20 GENE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MONITORING; ONCOGENE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPK2 GENE; UROTHELIUM;

EID: 84655174913     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.09.006     Document Type: Article

References (30)

1. S.K. Hong, C. Kwak, H.G. Jeon Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy? Urology 65 2005 697 702 (Pubitemid 40523002)
2. P. Gazzaniga, O. Gandini, L. Giuliani Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients Clin Cancer Res 7 2001 577 583 (Pubitemid 32707981)
3. T. Okegawa, M. Kinjo, K. Nutahara Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer J Urol 171 2004 1461 1466 (Pubitemid 38365395)
4. J.J. Lu, Y. Kakehi, T. Takahashi Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer Clin Cancer Res 6 2000 3166 3171 (Pubitemid 30637743)
5. M.J. Ribal, L. Mengual, M. Marín Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging Anticancer Res 26 2006 411 419 (Pubitemid 43206106)
6. J.M. Ahn, N. Rayamajhi, K.S. Gyun Comparison of real-time reverse transcriptase-polymerase chain reaction and nested or commercial reverse transcriptase-polymerase chain reaction for the detection of hepatitis E virus particle in human serum Diagn Microbiol Infect Dis 56 2006 269 274 (Pubitemid 44755019)
7. L. Mengual, M. Burset, M. Marin-Aguilera Multiplex preamplification of specific cDNA targets prior to gene expression analysis by TaqMan Arrays BMC Res Notes 1 2008 21
8. M. Marín-Aguilera, L. Mengual, M. Burset Molecular lymph node staging in bladder urothelial carcinoma: impact on survival Eur Urol 54 2008 1363 1372
9. W.K. Sobin TNM Classification of Malignant Tumours 6th ed. 2002 Wiley New York
10. A. Lopez-Beltran, G. Sauter, T. Gasser World Health Organization Classification of Tumours Pathology and Genetics Tumours of the Urinary System and Male Genital Organs 2004 IARC Lyon
11. X. Wu, Y. Kakehi, Y. Zeng Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20 J Urol 174 2005 2138 2142 (Pubitemid 41611755)
12. M.J. Seraj, A.R. Thomas, J.L. Chin Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder Clin Cancer Res 7 2001 1516 1522 (Pubitemid 32708614)
13. T. Kurahashi, I. Hara, N. Oka Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for focally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II Clin Cancer Res 11 2005 3773 3777 (Pubitemid 40685595)
14. C.J. Gdemann, J. Weitz, P. Kienle Detection of hematogenous micrometastasis in patients with transitional cell carcinoma J Urol 164 2000 532 536 (Pubitemid 30481979)
15. E. Beillard, N. Pallisgaard, d.V.V. Van Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using "real-time" quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)a Europe against cancer program Leukemia 17 2003 2474 2486 (Pubitemid 38072587)
16. M. Cristofanilli, G.T. Budd, M.J. Ellis Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351 2004 781 791 (Pubitemid 39095313)
17. M. Cristofanilli, K.R. Broglio, V. Guarneri Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden Clin Breast Cancer 7 2007 471 479 (Pubitemid 46424284)
18. M. Alunni-Fabbroni, M.T. Sandri Circulating tumour cells in clinical practice: methods of detection and possible characterization Methods 50 2010 289 297
19. A. Nezos, N. Pissimisis, P. Lembessis Detection of circulating tumor cells in bladder cancer patients Cancer Treat Rev 35 2009 272 279
20. Y. Fujii, Y. Kageyama, S. Kawakami Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction Jpn J Cancer Res 90 1999 753 757 (Pubitemid 29381105)
21. M. Naoe, Y. Ogawa, J. Morita Detection of circulating urothelial cancer cells in the blood using the CellSearch System Cancer 109 2007 1439 1445 (Pubitemid 46466573)
22. G.P. Gupta, J. Massagué Cancer metastasis: building a framework Cell 127 2006 679 695 (Pubitemid 44781029)
23. P. Liang, A.B. Pardee Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction Science 257 1992 967 971
24. K. Patel, P.J. Whelan, S. Prescott The use of real-time reverse transcription-PCR for prostate-specific antigen mRNA to discriminate between blood samples from healthy volunteers and from patients with metastatic prostate cancer Clin Cancer Res 10 2004 7511 7519 (Pubitemid 39557512)
25. S. Nagrath, L.V. Sequist, S. Maheswaran Isolation of rare circulating tumour cells in cancer patients by microchip technology Nature 450 2007 1235 1239
26. R.D. Mills, W.H. Turner, A. Fleischmann Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy J Urol 166 2001 19 23 (Pubitemid 32565332)
27. S. Madersbacher, W. Hochreiter, F. Burkhard Radical cystectomy for bladder cancer todaya homogeneous series without neoadjuvant therapy J Clin Oncol 21 2003 690 696 (Pubitemid 46621904)
28. B.R. Konety, S.A. Joslyn, M.A. O'Donnell Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base J Urol 169 2003 946 950 (Pubitemid 36188131)
29. I. Osman, D.F. Bajorin, T.T. Sun Novel blood biomarkers of human urinary bladder cancer Clin Cancer Res 12 2006 3374 3380
30. E.J. Kouba, A. Lentz, E.M. Wallen Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder Urol Oncol 27 2009 486 490